Paclitaxel and Capecitabine in Treating Women With Metastatic Breast Cancer

Completed · Phase 2

Conditions studied: Breast Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of paclitaxel and capecitabine in treating women who have metastatic breast cancer.

Key facts

Study ID

NCT00005649

Run by

Hoffmann-La Roche

Starts

1998-07-01

Expected to finish

2002-07-04

Last updated by the study team

2017-08-16

Who can join

Age: 18 and older, up to 75. Sex: female. Healthy volunteers: not accepted.

Where it is running

• PPD Development — Wilmington, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.